Oral Immune-Related Adverse Events - Current Concepts and their Management

Recent advent of immune checkpoint inhibitors (ICIs) have made significant improvement in the treatment outcome of cancer patients. They are also known to increase the overall survival in many malignancies. They target key immune checkpoints, acting on the cytotoxic T-lymphocyte antigen-4, programme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohamed Faizal Asan (Autor), Renita Lorina Castelino (Autor), Subhas G Babu (Autor), Kumuda Rao (Autor), Vaibhav Pandita (Autor)
Formato: Libro
Publicado: Elsevier, 2021-01-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible